Monoclonal Antibody Treatment
Richmond University Medical Center is suspending monoclonal antibody treatments for COVID-19, effective December 23.
Recently released, medically reviewed findings from the New York City Department of Health and Mental Hygiene (NYC DOHMH) have concluded that current monoclonal antibody treatments are not effective in treating illness caused by the omicron variant. Omicron now accounts for over 90 percent of COVID-19 cases in New York State. RUMC, along with many healthcare facilities across New York City, is suspending treatments based on this evidence. Once newer, more effective treatments for COVID-19 are available, or more information is available, we will inform the community.
If you have been diagnosed with COVID-19, please contact your primary care doctor for next steps. For the latest information on COVID-19, the omicron variant, and recommended precautions to reduce spread, visit our website at RUMCSI.org or go to the websites for the Centers for Disease Control and Prevention (CDC), New York State Department of Health, or New York City Department of Health and Mental Hygiene.